http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#head
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc
http://www.nanopub.org/nschema#hasAssertion
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#assertion
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc
http://www.nanopub.org/nschema#hasProvenance
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#provenance
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc
http://www.nanopub.org/nschema#hasPublicationInfo
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#assertion
http://rdf.disgenet.org/resource/gda/DGN5db8bf3b008f275f6b7b5f55f5971351
http://semanticscience.org/resource/SIO_000628
http://identifiers.org/ncbigene/142
http://rdf.disgenet.org/resource/gda/DGN5db8bf3b008f275f6b7b5f55f5971351
http://semanticscience.org/resource/SIO_000628
http://linkedlifedata.com/resource/umls/id/C0029925
http://rdf.disgenet.org/resource/gda/DGN5db8bf3b008f275f6b7b5f55f5971351
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://semanticscience.org/resource/SIO_001123
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#provenance
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#assertion
http://purl.org/dc/terms/description
[In this study, we examined the respective roles of the ATR and Chk1 kinases in ovarian cancer cells using genetic and pharmacologic inhibitors in combination with cisplatin, topotecan, gemcitabine, and the PARP inhibitor veliparib (ABT-888), four agents with clinical activity in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#assertion
http://purl.org/ontology/wi/core#evidence
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#assertion
http://semanticscience.org/resource/SIO_000772
http://identifiers.org/pubmed/23548269
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#assertion
http://www.w3.org/ns/prov#wasDerivedFrom
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#assertion
http://www.w3.org/ns/prov#wasGeneratedBy
http://purl.obolibrary.org/obo/ECO_0000203
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://purl.org/pav/importedOn
2017-02-19
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.obolibrary.org/obo/ECO_0000212
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#comment
Gene-disease associations inferred from text-mining the literature.
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#label
DisGeNET evidence - LITERATURE
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc
http://purl.org/dc/terms/created
2017-10-17T13:10:17+02:00
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc
http://purl.org/dc/terms/rights
http://opendatacommons.org/licenses/odbl/1.0/
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc
http://purl.org/dc/terms/rightsHolder
http://rdf.disgenet.org/v5.0.0/void/IBIGroup
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc
http://purl.org/dc/terms/subject
http://semanticscience.org/resource/SIO_000983
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc
http://purl.org/net/provenance/ns#usedData
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc
http://purl.org/pav/authoredBy
http://orcid.org/0000-0001-5999-6269
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-7534-7661
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-9383-528X
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-1244-7654
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc
http://purl.org/pav/createdBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP16637.RASHB5nzAQjNY2LGsWG2y_iMC0YuUqsc2xhCyFRSHvIDc
http://purl.org/pav/version
v5.0.0.0
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://purl.org/pav/version
v5.0.0